What does CUSIP 04351P101 represent in this 13F holders report?

CUSIP 04351P101 is the security identifier for ASND - Ascendis Pharma A/S - American Depositary Shares used to aggregate holder disclosures.

How many institutions held ASND - Ascendis Pharma A/S - American Depositary Shares in Q1 2020?

143 institutional investors reported ASND - Ascendis Pharma A/S - American Depositary Shares for Q1 2020. Use the holders table for investor-level position and value details.

Ascendis Pharma A/S - American Depositary Shares (ASND)

CUSIP: 04351P101

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / American Depositary Shares
Shares outstanding: 61,990,867
Total 13F shares: 47,871,754
Share change: +1,821,383
Total reported value: $5,391,239,456
Put/Call ratio: 30%
Price per share: $112.61
Number of holders: 143
Value change: +$191,350,357
Number of buys: 65
Number of sells: 80

Quarterly Holders Quick Answers

What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - American Depositary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 04351P101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ASND - Ascendis Pharma A/S - American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	13%	7,761,296	$1,079,751,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	7.7%	4,773,954	$664,152,000	—	31 Dec 2019	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	6.8%	4,185,342	$582,265,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	5.5%	3,390,270	$471,654,000	—	31 Dec 2019	13F
ORBIMED ADVISORS LLC	13F	Company	5.4%	3,343,100	$465,092,000	—	31 Dec 2019	13F
Artisan Partners Limited Partnership	13F	Company	3.5%	2,156,396	$299,998,000	—	31 Dec 2019	13F
Avoro Capital Advisors LLC	13F	Company	3%	1,865,000	$259,459,000	—	31 Dec 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.8%	1,717,335	$238,916,000	—	31 Dec 2019	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.7%	1,698,648	$236,316,000	—	31 Dec 2019	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	2.1%	1,279,000	$177,934,000	—	31 Dec 2019	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	2%	1,260,756	$175,396,000	—	31 Dec 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	2%	1,253,004	$174,318,000	—	31 Dec 2019	13F
Sofinnova Investments, Inc.	13F	Company	1.8%	1,109,874	$154,406,000	—	31 Dec 2019	13F
FRANKLIN RESOURCES INC	13F	Company	1.3%	818,742	$113,904,000	—	31 Dec 2019	13F
Camber Capital Management LP	13F	Company	1.1%	663,000	$92,237,000	—	31 Dec 2019	13F
Invesco Ltd.	13F	Company	0.96%	593,323	$82,543,000	—	31 Dec 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.88%	544,965	$75,815,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.87%	537,086	$74,719,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.79%	488,762	$67,997,000	—	31 Dec 2019	13F
Marshall Wace North America L.P.	13F	Company	0.76%	471,619	$65,612,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	0.68%	423,548	$58,924,000	—	31 Dec 2019	13F
Cormorant Asset Management, LP	13F	Company	0.65%	400,000	$55,648,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.53%	329,682	$45,866,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.44%	274,000	$38,118,000	—	31 Dec 2019	13F
LAKEWOOD CAPITAL MANAGEMENT, LP	13F	Company	0.44%	270,450	$37,625,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.41%	257,083	$35,765,000	—	31 Dec 2019	13F
Spyglass Capital Management LLC	13F	Company	0.4%	250,972	$34,915,000	—	31 Dec 2019	13F
Rock Springs Capital Management LP	13F	Company	0.34%	213,500	$29,702,000	—	31 Dec 2019	13F
Eversept Partners, LP	13F	Company	0.33%	202,894	$28,226,613	—	31 Dec 2019	13F
Ghost Tree Capital, LLC	13F	Company	0.32%	200,000	$27,824,000	—	31 Dec 2019	13F
Logos Global Management LP	13F	Company	0.29%	179,898	$25,027,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.29%	178,161	$24,786,000	—	31 Dec 2019	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.28%	173,947	$24,199,000	—	31 Dec 2019	13F
FIL Ltd	13F	Company	0.27%	169,636	$23,556,000	—	31 Dec 2019	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.25%	155,412	$21,621,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.22%	134,117	$18,658,000	—	31 Dec 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.2%	122,204	$17,001,000	—	31 Dec 2019	13F
LOOMIS SAYLES & CO L P	13F	Company	0.19%	117,881	$16,399,000	—	31 Dec 2019	13F
Melqart Asset Management (UK) Ltd	13F	Company	0.19%	115,404	$16,055,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.18%	112,000	$15,581,000	—	31 Dec 2019	13F
Artal Group S.A.	13F	Company	0.16%	100,000	$13,912,000	—	31 Dec 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.16%	98,433	$13,694,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.15%	95,537	$13,291,000	—	31 Dec 2019	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.15%	94,500	$13,146,000	—	31 Dec 2019	13F
WESTPAC BANKING CORP	13F	Company	0.13%	83,039	$11,552,385	—	31 Dec 2019	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.12%	73,773	$10,263,000	—	31 Dec 2019	13F
Tekla Capital Management LLC	13F	Company	0.11%	69,332	$9,645,000	—	31 Dec 2019	13F
Foresite Capital Management IV, LLC	13F	Company	0.11%	68,981	$9,597,000	—	31 Dec 2019	13F
SEI INVESTMENTS CO	13F	Company	0.11%	65,908	$9,169,000	—	31 Dec 2019	13F
Neuberger Berman Group LLC	13F	Company	0.1%	64,669	$8,997,000	—	31 Dec 2019	13F

Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q1 2020

As of 31 Mar 2020, Ascendis Pharma A/S - American Depositary Shares (ASND) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,871,754 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., FMR LLC, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, Artisan Partners Limited Partnership, Vivo Capital, LLC, JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 143 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

139

Q1 2020 holders

143

Holder diff

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.